{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:25:53Z","timestamp":1791822353202,"version":"4.3.4"},"reference-count":252,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82425046"],"award-info":[{"award-number":["82425046"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573226"],"award-info":[{"award-number":["82573226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82421002"],"award-info":[{"award-number":["82421002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.canlet.2026.218305","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:54:18Z","timestamp":1770479658000},"page":"218305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The role of the microbiota in cancer drug resistance and emerging therapeutic strategies"],"prefix":"10.1016","volume":"642","author":[{"given":"Chang","family":"Che","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sifan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiming","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0194-8074","authenticated-orcid":false,"given":"Yuanyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1817-803X","authenticated-orcid":false,"given":"Xiaodi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.canlet.2026.218305_bib1","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41591-022-01779-2","article-title":"Targeting the gut and tumor microbiota in cancer","volume":"28","author":"Park","year":"2022","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.canlet.2026.218305_bib2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.trecan.2022.06.009","article-title":"Drug independence and the curability of cancer by combination chemotherapy","volume":"8","author":"Pomeroy","year":"2022","journal-title":"Trends Cancer"},{"issue":"8","key":"10.1016\/j.canlet.2026.218305_bib3","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.3324\/haematol.2024.285825","article-title":"Combination chemotherapy for hodgkin lymphoma","volume":"109","author":"Moskowitz","year":"2024","journal-title":"Haematologica"},{"issue":"14","key":"10.1016\/j.canlet.2026.218305_bib4","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/CM9.0000000000002631","article-title":"Assessment of the safety and efficacy of combination chemotherapy and PD-1\/PD-L1 inhibitor treatment of breast cancer: a meta-analysis","volume":"136","author":"Qian","year":"2023","journal-title":"Chin. Med. J. (Engl. Ed.)"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2015.04.009","article-title":"Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer","volume":"363","author":"Frank","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218305_bib6","article-title":"Efficacy and safety of SHR-1701 combined with chemoradiotherapy as neoadjuvant treatment for locally advanced rectal cancer","author":"Tang","year":"2025","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.canlet.2026.218305_bib7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1053\/j.gastro.2019.10.038","article-title":"ZIP4 increases expression of transcription factor ZEB1 to promote integrin \u03b13\u03b21 signaling and inhibit expression of the gemcitabine transporter ENT1 in pancreatic cancer cells","volume":"158","author":"Liu","year":"2020","journal-title":"Gastroenterology"},{"issue":"24","key":"10.1016\/j.canlet.2026.218305_bib8","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1200\/JCO-25-00374","article-title":"Microbiome modulation for the treatment of solid neoplasms","volume":"43","author":"Barragan-Carrillo","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218305_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217274","article-title":"Current status and prospect of gut and oral microbiome in pancreatic cancer: clinical and translational perspectives","volume":"604","author":"Li","year":"2024","journal-title":"Cancer Lett."},{"issue":"24","key":"10.1016\/j.canlet.2026.218305_bib10","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1158\/0008-5472.CAN-22-0455","article-title":"Disruption of the gut microbiota confers cisplatin resistance in epithelial ovarian cancer","volume":"82","author":"Chambers","year":"2022","journal-title":"Cancer Res."},{"issue":"6649","key":"10.1016\/j.canlet.2026.218305_bib11","doi-asserted-by":"crossref","first-page":"eabo2296","DOI":"10.1126\/science.abo2296","article-title":"A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers","volume":"380","author":"Fidelle","year":"2023","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.canlet.2026.218305_bib12","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","article-title":"Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer","volume":"185","author":"Fu","year":"2022","journal-title":"Cell"},{"issue":"7937","key":"10.1016\/j.canlet.2026.218305_bib13","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","article-title":"Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer","volume":"611","author":"Galeano Ni\u00f1o","year":"2022","journal-title":"Nature"},{"issue":"7782","key":"10.1016\/j.canlet.2026.218305_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.canlet.2026.218305_bib15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.trecan.2019.02.003","article-title":"Polytherapy and targeted cancer drug resistance","volume":"5","author":"Chatterjee","year":"2019","journal-title":"Trends Cancer"},{"issue":"11-12","key":"10.1016\/j.canlet.2026.218305_bib16","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s12272-023-01471-0","article-title":"Selumetinib overcomes gefitinib primary and acquired resistance by regulating MIG6\/STAT3 in NSCLC","volume":"46","author":"Song","year":"2023","journal-title":"Arch Pharm. Res. (Seoul)"},{"issue":"5","key":"10.1016\/j.canlet.2026.218305_bib17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cac2.12539","article-title":"Immunologic tumor microenvironment modulators for turning cold tumors hot","volume":"44","author":"Khosravi","year":"2024","journal-title":"Cancer Commun."},{"issue":"3","key":"10.1016\/j.canlet.2026.218305_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.20517\/cdr.2023.33","article-title":"Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma","volume":"6","author":"Astore","year":"2023","journal-title":"Cancer Drug Resist."},{"issue":"5","key":"10.1016\/j.canlet.2026.218305_bib19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ccell.2018.03.025","article-title":"A convergence-based framework for cancer drug resistance","volume":"33","author":"Konieczkowski","year":"2018","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.canlet.2026.218305_bib20","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1158\/2159-8290.CD-23-0656","article-title":"Acquired cross-resistance in small cell lung cancer due to extrachromosomal DNA amplification of MYC paralogs","volume":"14","author":"Pal Choudhuri","year":"2024","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.canlet.2026.218305_bib21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2011.07.026","article-title":"Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells","volume":"146","author":"Gupta","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10555-024-10172-z","article-title":"Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance","volume":"43","author":"Bhat","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2026.218305_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10690","article-title":"Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells","volume":"7","author":"Ramirez","year":"2016","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.canlet.2026.218305_bib24","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nm.4369","article-title":"An approach to suppress the evolution of resistance in BRAF(V600E)-mutant cancer","volume":"23","author":"Xue","year":"2017","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.canlet.2026.218305_bib25","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2023.02.008","article-title":"The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients","volume":"41","author":"Friedrich","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218305_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114643","article-title":"Overcoming cancer Multi-drug resistance (MDR): Reasons, mechanisms, nanotherapeutic solutions, and challenges","volume":"162","author":"Duan","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2026.218305_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216368","article-title":"SEM1 promotes tumor progression of glioblastoma via activating the akt signaling pathway","volume":"577","author":"Li","year":"2023","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.canlet.2026.218305_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70003","article-title":"LINC01764 promotes colorectal cancer cells proliferation, metastasis, and 5-fluorouracil resistance by regulating glucose and glutamine metabolism via promoting c-MYC translation","volume":"5","author":"Duan","year":"2024","journal-title":"MedComm"},{"issue":"16","key":"10.1016\/j.canlet.2026.218305_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169108","article-title":"Hepatocyte growth factor enhances antineoplastic effect of 5-Fluorouracil by increasing UPP1 expression in HepG2 cells","volume":"23","author":"Okumura","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.canlet.2026.218305_bib30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1634\/theoncologist.7-4-288","article-title":"Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review","volume":"7","author":"Malet-Martino","year":"2002","journal-title":"Oncologist"},{"issue":"5531","key":"10.1016\/j.canlet.2026.218305_bib31","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12943-024-02162-0","article-title":"Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL+ leukemia stem cells","volume":"23","author":"Zeng","year":"2024","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.canlet.2026.218305_bib33","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.tibtech.2024.06.007","article-title":"Bioprinted, spatially defined breast tumor microenvironment models of intratumoral heterogeneity and drug resistance","volume":"42","author":"Yuan","year":"2024","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.canlet.2026.218305_bib34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","article-title":"Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance","volume":"18","author":"Sherman","year":"2023","journal-title":"Annu. Rev. Pathol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218305_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41587-024-02271-7","article-title":"Programming tumor evolution with selection gene drives to proactively combat drug resistance","volume":"43","author":"Leighow","year":"2025","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.canlet.2026.218305_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115229","article-title":"The spatial landscape of cancer hallmarks reveals patterns of tumor ecological dynamics and drug sensitivity","volume":"44","author":"Sibai","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218305_bib37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.semcancer.2020.02.013","article-title":"Small-molecule drug repurposing to target DNA damage repair and response pathways","volume":"68","author":"Brinkman","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2026.218305_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101148","article-title":"The important role of lactylation in regulating DNA damage repair and tumor chemotherapy resistance","volume":"78","author":"Li","year":"2025","journal-title":"Drug Resist. Updates"},{"issue":"3","key":"10.1016\/j.canlet.2026.218305_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00018-022-04129-0","article-title":"METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability","volume":"79","author":"Li","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.canlet.2026.218305_bib40","first-page":"621","article-title":"The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells","volume":"52","author":"Taketo","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2026.218305_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2019.100663","article-title":"Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance","volume":"48","author":"Narayanan","year":"2020","journal-title":"Drug Resist. Updates"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib42","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12943-022-01680-z","article-title":"Biological and pharmacological roles of m(6)A modifications in cancer drug resistance","volume":"21","author":"Liu","year":"2022","journal-title":"Mol. Cancer"},{"issue":"17","key":"10.1016\/j.canlet.2026.218305_bib43","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1158\/0008-5472.CAN-22-4017","article-title":"SENP1 decreases RNF168 phase separation to promote DNA damage repair and drug resistance in Colon cancer","volume":"83","author":"Wei","year":"2023","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12943-024-01990-4","article-title":"Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer","volume":"23","author":"Kundu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218305_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.656364","article-title":"Aspects of the tumor microenvironment involved in immune resistance and drug resistance","volume":"12","author":"Khalaf","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13045-024-01634-6","article-title":"Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition","volume":"18","author":"Glaviano","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218305_bib47","article-title":"Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"issue":"6320","key":"10.1016\/j.canlet.2026.218305_bib48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aah4307","article-title":"SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer","volume":"355","author":"Mu","year":"2017","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.canlet.2026.218305_bib49","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1158\/1078-0432.CCR-18-0653","article-title":"TMPRSS2-ERG controls luminal epithelial lineage and antiandrogen sensitivity in PTEN and TP53-Mutated prostate cancer","volume":"24","author":"Blee","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218305_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115663","article-title":"Inhibition of murine colorectal cancer metastasis by targeting M2-TAM through STAT3\/NF-kB\/AKT signaling using macrophage 1-derived extracellular vesicles loaded with oxaliplatin, retinoic acid, and Libidibia ferrea","volume":"168","author":"de Carvalho","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.canlet.2026.218305_bib51","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.cell.2024.03.011","article-title":"Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8(+) T cells","volume":"187","author":"Cao","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib52","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218305_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1479795","article-title":"Urinary microbiota changes among NMIBC patients during BCG therapy: comparing BCG responders and non-responders","volume":"15","author":"Boban","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"11","key":"10.1016\/j.canlet.2026.218305_bib54","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamaoto.2025.2816","article-title":"Oral lachnoanaerobaculum levels and survival in patients with head and neck cancer","volume":"151","author":"R\u00fchle","year":"2025","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.canlet.2026.218305_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217149","article-title":"Intratumoral microbiome promotes liver metastasis and dampens adjuvant imatinib treatment in gastrointestinal stromal tumor","volume":"601","author":"Li","year":"2024","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.canlet.2026.218305_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/biom15071018","article-title":"Role of oral bacteria in mediating gemcitabine resistance in pancreatic cancer","volume":"15","author":"Xu","year":"2025","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10555-023-10138-7","article-title":"The emerging role of the gut microbiome in cancer cell plasticity and therapeutic resistance","volume":"43","author":"Mondal","year":"2024","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib58","article-title":"Current understanding of the intratumoral microbiome in various tumors","volume":"4","author":"Xue","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib59","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s40168-025-02114-w","article-title":"Tissue-resident microbiota signature in nasopharyngeal carcinoma","volume":"13","author":"Tan","year":"2025","journal-title":"Microbiome"},{"issue":"20","key":"10.1016\/j.canlet.2026.218305_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252011157","article-title":"Differential urinary microbiome and its metabolic footprint in bladder cancer patients following BCG treatment","volume":"25","author":"Min","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.canlet.2026.218305_bib61","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","article-title":"Interaction between drugs and the gut microbiome","volume":"69","author":"Weersma","year":"2020","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.canlet.2026.218305_bib62","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","article-title":"Gut microbiota modulation of chemotherapy efficacy and toxicity","volume":"14","author":"Alexander","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6161","key":"10.1016\/j.canlet.2026.218305_bib63","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1240537","article-title":"The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide","volume":"342","author":"Viaud","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib64","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2374596","article-title":"Microbiome and pancreatic cancer: time to think about chemotherapy","volume":"16","author":"de Castilhos","year":"2024","journal-title":"Gut Microbes"},{"issue":"11","key":"10.1016\/j.canlet.2026.218305_bib65","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1136\/gutjnl-2023-330291","article-title":"Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8(+) T cells","volume":"72","author":"Kang","year":"2023","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.canlet.2026.218305_bib66","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.cmet.2023.04.015","article-title":"Lactobacillus plantarum-derived indole-3-lactic acid ameliorates colorectal tumorigenesis via epigenetic regulation of CD8(+) T cell immunity","volume":"35","author":"Zhang","year":"2023","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.canlet.2026.218305_bib67","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","article-title":"Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack","volume":"42","author":"Gur","year":"2015","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.canlet.2026.218305_bib68","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1581531","article-title":"Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1","volume":"8","author":"Gur","year":"2019","journal-title":"OncoImmunology"},{"issue":"4","key":"10.1016\/j.canlet.2026.218305_bib69","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/10428194.2020.1850718","article-title":"Investigating the gut microbial community and genes in children with differing levels of change in serum asparaginase activity during pegaspargase treatment for acute lymphoblastic leukemia","volume":"62","author":"Dunn","year":"2021","journal-title":"Leuk. Lymphoma"},{"issue":"3","key":"10.1016\/j.canlet.2026.218305_bib70","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2017.03.040","article-title":"Host-microbe Co-metabolism dictates cancer drug efficacy in C. elegans","volume":"169","author":"Scott","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib71","article-title":"The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib72","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12866-023-02791-3","article-title":"Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity","volume":"23","author":"Mahdy","year":"2023","journal-title":"BMC Microbiol."},{"issue":"7762","key":"10.1016\/j.canlet.2026.218305_bib73","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218305_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124663","article-title":"Investigating drug-gut microbiota interactions: reductive and hydrolytic metabolism of oral glucocorticoids by in vitro artificial gut microbiota","volume":"665","author":"Viglioli","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.canlet.2026.218305_bib75","doi-asserted-by":"crossref","DOI":"10.1038\/srep14554","article-title":"Local bacteria affect the efficacy of chemotherapeutic drugs","volume":"5","author":"Lehouritis","year":"2015","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.canlet.2026.218305_bib76","doi-asserted-by":"crossref","first-page":"13054","DOI":"10.1074\/jbc.M114.558924","article-title":"Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine","volume":"289","author":"Vande Voorde","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"26","key":"10.1016\/j.canlet.2026.218305_bib77","article-title":"\u03b2-Glucuronidase-Expressing Lactobacillus reuteri triggers Irinotecan enterotoxicity through depleting the regenerative epithelial stem\/progenitor pool","volume":"12","author":"Yue","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218305_bib78","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.phrs.2018.10.029","article-title":"Pharmacological inhibition of bacterial \u03b2-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo","volume":"139","author":"Cheng","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.canlet.2026.218305_bib79","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/cbdd.13655","article-title":"Identify old drugs as selective bacterial \u03b2-GUS inhibitors by structural-based virtual screening and bio-evaluations","volume":"95","author":"Chen","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib80","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s42003-021-01815-w","article-title":"Entropy-driven binding of gut bacterial \u03b2-glucuronidase inhibitors ameliorates irinotecan-induced toxicity","volume":"4","author":"Lin","year":"2021","journal-title":"Commun. Biol."},{"issue":"13","key":"10.1016\/j.canlet.2026.218305_bib81","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1073\/pnas.1918095117","article-title":"Targeted inhibition of gut bacterial \u03b2-glucuronidase activity enhances anticancer drug efficacy","volume":"117","author":"Bhatt","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.canlet.2026.218305_bib82","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1002\/bcp.70152","article-title":"ABCC4 polymorphism indirectly reduces systemic exposure to a capecitabine metabolite 5\u2019-deoxy-5-fluorouridine in Japanese subjects","volume":"91","author":"Matsumoto","year":"2025","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.canlet.2026.218305_bib83","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1016\/j.apsb.2024.09.018","article-title":"Targeted inhibition of Gus-expressing Enterococcus faecalis to promote intestinal stem cell and epithelial renovation contributes to the relief of irinotecan chemotoxicity by dehydrodiisoeugenol","volume":"14","author":"Gao","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.canlet.2026.218305_bib84","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1136\/gutjnl-2021-326264","article-title":"Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes","volume":"71","author":"Ting","year":"2022","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244876","article-title":"Predicting drug-metagenome interactions: variation in the microbial \u03b2-glucuronidase level in the human gut metagenomes","volume":"16","author":"Elmassry","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib86","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/17425255.2022.2043849","article-title":"Gut microbiota-drug interactions in cancer pharmacotherapies: implications for efficacy and adverse effects","volume":"18","author":"Leigh","year":"2022","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.canlet.2026.218305_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152858","article-title":"The efficacy and toxicity of antineoplastic antimetabolites: role of gut microbiota","volume":"460","author":"Huang","year":"2021","journal-title":"Toxicology"},{"issue":"10","key":"10.1016\/j.canlet.2026.218305_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12102263","article-title":"The association between the firmicutes\/bacteroidetes ratio and body mass among European population with the highest proportion of adults with obesity: an observational Follow-Up study from Croatia","volume":"12","author":"Kara\u010di\u0107","year":"2024","journal-title":"Biomedicines"},{"issue":"7698","key":"10.1016\/j.canlet.2026.218305_bib89","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nature25979","article-title":"Extensive impact of non-antibiotic drugs on human gut bacteria","volume":"555","author":"Maier","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218305_bib90","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbi.2019.02.020","article-title":"Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota","volume":"80","author":"Sougiannis","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.canlet.2026.218305_bib91","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1007\/s12602-024-10324-1","article-title":"Pediococcus pentosaceus PP34 Ameliorates 5-Fluorouracil-Induced Intestinal Mucositis via Inhibiting Oxidative Stress and Restoring the Gut Microbiota","volume":"17","author":"He","year":"2025","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10.1016\/j.canlet.2026.218305_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111152","article-title":"Neutrophil elastase inhibitor (MPH-966) improves intestinal mucosal damage and gut microbiota in a mouse model of 5-fluorouracil-induced intestinal mucositis","volume":"134","author":"Chen","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.canlet.2026.218305_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12081912","article-title":"Effects of resistant-starch-encapsulated probiotic cocktail on intestines damaged by 5-Fluorouracil","volume":"12","author":"Wang","year":"2024","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.canlet.2026.218305_bib94","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4161\/cbt.7.12.6940","article-title":"Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats","volume":"7","author":"Stringer","year":"2008","journal-title":"Cancer Biol. Ther."},{"issue":"4","key":"10.1016\/j.canlet.2026.218305_bib95","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.immuni.2016.09.009","article-title":"Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects","volume":"45","author":"Daill\u00e8re","year":"2016","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.canlet.2026.218305_bib96","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/procel\/pwad052","article-title":"Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets","volume":"15","author":"Dai","year":"2024","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib97","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1038\/s41467-020-18649-5","article-title":"Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients","volume":"11","author":"Daisley","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.canlet.2026.218305_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039764","article-title":"Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.canlet.2026.218305_bib99","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.eururo.2020.04.044","article-title":"Gut bacteria composition drives primary resistance to cancer immunotherapy in renal cell carcinoma patients","volume":"78","author":"Derosa","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2026.218305_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217456","article-title":"Oral and fecal microbiota as accurate non-invasive tools for detection of pancreatic cancer in the Chinese population","volume":"612","author":"Li","year":"2025","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.canlet.2026.218305_bib101","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1038\/s41418-021-00753-8","article-title":"Multifaceted modes of action of the anticancer probiotic Enterococcus hirae","volume":"28","author":"Goubet","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2026.218305_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102925","article-title":"Cisplatin: the first metal based anticancer drug","volume":"88","author":"Ghosh","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.canlet.2026.218305_bib103","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/cas.15666","article-title":"Probiotics enhances anti-tumor immune response induced by gemcitabine plus cisplatin chemotherapy for urothelial cancer","volume":"114","author":"Miyake","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2026.218305_bib104","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2969287","article-title":"Akkermansia muciniphila enhances the antitumor effect of cisplatin in lewis lung cancer mice","volume":"2020","author":"Chen","year":"2020","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.canlet.2026.218305_bib105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijbiomac.2022.10.256","article-title":"Cisplatin conjugation with an exopolysaccharide extracted from Lactobacillus gasseri potentiates its efficacy and attenuates its toxicity","volume":"225","author":"Sharma","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.canlet.2026.218305_bib106","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.biopha.2018.08.165","article-title":"The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer","volume":"108","author":"Yuan","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.canlet.2026.218305_bib107","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","article-title":"Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy","volume":"170","author":"Yu","year":"2017","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.canlet.2026.218305_bib108","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.7150\/thno.70754","article-title":"Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis","volume":"12","author":"Ghosh","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib109","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2186114","article-title":"Therapeutic potential of Clostridium butyricum anticancer effects in colorectal cancer","volume":"15","author":"Xu","year":"2023","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12934-020-01330-3","article-title":"Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma","volume":"19","author":"Kesh","year":"2020","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.canlet.2026.218305_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106406","article-title":"Effect of Bifidobacterium animalis subsp. lactis SF on enhancing the tumor suppression of Irinotecan by regulating the intestinal flora","volume":"184","author":"Ren","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib112","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40168-020-00811-2","article-title":"Predictable modulation of cancer treatment outcomes by the gut microbiota","volume":"8","author":"Heshiki","year":"2020","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib113","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/HEP.0000000000000047","article-title":"Gut microbial metabolite butyrate improves anticancer therapy by regulating intracellular calcium homeostasis","volume":"78","author":"Che","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib114","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2096328","article-title":"Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC","volume":"14","author":"Kesh","year":"2022","journal-title":"Gut Microbes"},{"issue":"17","key":"10.1016\/j.canlet.2026.218305_bib115","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.7150\/thno.73873","article-title":"Depletion of gut microbiota improves the therapeutic efficacy of cancer nanomedicine","volume":"12","author":"Prajnamitra","year":"2022","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.canlet.2026.218305_bib116","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/j.gastro.2019.10.020","article-title":"Western diet promotes intestinal colonization by collagenolytic microbes and promotes tumor formation after colorectal surgery","volume":"158","author":"Gaines","year":"2020","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.canlet.2026.218305_bib117","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijrobp.2022.07.032","article-title":"Gut microbiome is associated with the response to chemoradiotherapy in patients with non-small cell lung cancer","volume":"115","author":"Qiu","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib118","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12964-024-01711-w","article-title":"Mechanisms, combination therapy, and biomarkers in cancer immunotherapy resistance","volume":"22","author":"Yang","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.canlet.2026.218305_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217096","article-title":"Gut microbial metabolites in lung cancer development and immunotherapy: novel insights into gut-lung axis","volume":"598","author":"Li","year":"2024","journal-title":"Cancer Lett."},{"issue":"6371","key":"10.1016\/j.canlet.2026.218305_bib120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"issue":"6529","key":"10.1016\/j.canlet.2026.218305_bib121","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.canlet.2026.218305_bib122","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ccell.2025.02.010","article-title":"Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.canlet.2026.218305_bib123","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41577-023-00951-0","article-title":"Role of the microbiota in response to and recovery from cancer therapy","volume":"24","author":"Blake","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"6371","key":"10.1016\/j.canlet.2026.218305_bib124","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218305_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216582","article-title":"Gut microbiota: a double-edged sword in immune checkpoint blockade immunotherapy against tumors","volume":"582","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.canlet.2026.218305_bib126","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1136\/gutjnl-2020-321031","article-title":"Ginseng polysaccharides alter the gut microbiota and kynurenine\/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1\/programmed cell death ligand 1 (anti-PD-1\/PD-L1) immunotherapy","volume":"71","author":"Huang","year":"2022","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.canlet.2026.218305_bib127","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1158\/2326-6066.CIR-20-0051","article-title":"Association of probiotic Clostridium butyricum therapy with survival and response to immune checkpoint blockade in patients with lung cancer","volume":"8","author":"Tomita","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"9","key":"10.1016\/j.canlet.2026.218305_bib128","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1158\/2159-8290.CD-24-1230","article-title":"Gut microbiota modulation through akkermansia spp. supplementation increases CAR T-cell potency","volume":"15","author":"Marcos-Kovandzic","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218305_bib129","article-title":"Gut microbiota composition in chemotherapy and targeted therapy of patients with metastatic colorectal cancer","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218305_bib130","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/annonc\/mdx108","article-title":"Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab","volume":"28","author":"Chaput","year":"2017","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.canlet.2026.218305_bib131","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.neo.2017.08.004","article-title":"Metagenomic shotgun sequencing and unbiased metabolomic profiling identify specific human gut microbiota and metabolites associated with immune checkpoint therapy efficacy in melanoma patients","volume":"19","author":"Frankel","year":"2017","journal-title":"Neoplasia"},{"issue":"8","key":"10.1016\/j.canlet.2026.218305_bib132","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1158\/0008-5472.CAN-20-1659","article-title":"Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-Positive breast cancer","volume":"81","author":"Di Modica","year":"2021","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.canlet.2026.218305_bib133","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41591-022-01694-6","article-title":"Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial","volume":"28","author":"Dizman","year":"2022","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib134","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2197836","article-title":"Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression and chemoresistance by enhancing the secretion of chemotherapy-induced senescence-associated secretory phenotype via activation of DNA damage response pathway","volume":"15","author":"Zhang","year":"2023","journal-title":"Gut Microbes"},{"issue":"15","key":"10.1016\/j.canlet.2026.218305_bib135","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1182\/blood.2023021671","article-title":"Staphylococcus aureus induces drug resistance in cancer T cells in s\u00e9zary syndrome","volume":"143","author":"Vadivel","year":"2024","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.canlet.2026.218305_bib136","article-title":"A review of gut microbiota-derived metabolites in tumor progression and cancer therapy","volume":"10","author":"Yang","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218305_bib137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2025.07.005","article-title":"Host-microbiota interactions in genitourinary cancer immunotherapy","volume":"115","author":"Xu","year":"2025","journal-title":"Semin. Cancer Biol."},{"issue":"7802","key":"10.1016\/j.canlet.2026.218305_bib138","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","article-title":"Mutational signature in colorectal cancer caused by genotoxic pks(+) E. coli","volume":"580","author":"Pleguezuelos-Manzano","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.canlet.2026.218305_bib139","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccell.2024.02.009","article-title":"Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer","volume":"42","author":"Rosendahl Huber","year":"2024","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib140","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ccell.2022.11.013","article-title":"Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer","volume":"41","author":"Teng","year":"2023","journal-title":"Cancer Cell"},{"issue":"6356","key":"10.1016\/j.canlet.2026.218305_bib141","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aah5043","article-title":"Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine","volume":"357","author":"Geller","year":"2017","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.canlet.2026.218305_bib142","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/14737159.2018.1544495","article-title":"The microbiome of pancreatic cancer: from molecular diagnostics to new therapeutic approaches to overcome chemoresistance caused by metabolic inactivation of gemcitabine","volume":"18","author":"Choy","year":"2018","journal-title":"Expert Rev. Mol. Diagn"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib143","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2333790","article-title":"Fusobacterium nucleatum induces chemoresistance in colorectal cancer by inhibiting pyroptosis via the hippo pathway","volume":"16","author":"Wang","year":"2024","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib144","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40168-022-01289-w","article-title":"Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-\u03baB-IL6-STAT3 axis","volume":"10","author":"Zhong","year":"2022","journal-title":"Microbiome"},{"issue":"6","key":"10.1016\/j.canlet.2026.218305_bib145","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/procel\/pwae005","article-title":"Microbiota enterotoxigenic bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1","volume":"15","author":"Ma","year":"2024","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib146","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/07853890.2022.2061045","article-title":"Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance","volume":"54","author":"Liang","year":"2022","journal-title":"Ann. Med."},{"issue":"6","key":"10.1016\/j.canlet.2026.218305_bib147","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41591-019-0458-7","article-title":"Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer","volume":"25","author":"Yachida","year":"2019","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.canlet.2026.218305_bib148","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1101\/gr.126516.111","article-title":"Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma","volume":"22","author":"Castellarin","year":"2012","journal-title":"Genome Res."},{"issue":"10","key":"10.1016\/j.canlet.2026.218305_bib149","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.annonc.2020.06.003","article-title":"Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer","volume":"31","author":"Serna","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2026.218305_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217810","article-title":"Fusobacterium nucleatum enhances cholesterol biosynthesis in colorectal cancer via miR-130a-3p-mediated AMPK inhibition, a process counteracted by butyrate","volume":"627","author":"Sun","year":"2025","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib151","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13046-018-0985-y","article-title":"Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer","volume":"38","author":"Zhang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.canlet.2026.218305_bib152","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1620\/tjem.253.249","article-title":"Fusobacterium nucleatum promotes cisplatin-resistance and migration of oral squamous carcinoma cells by Up-Regulating Wnt5a-Mediated NFATc3 expression","volume":"253","author":"Da","year":"2021","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.canlet.2026.218305_bib153","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.2147\/CMAR.S185766","article-title":"Fusobacterium nucleatum prevents apoptosis in colorectal cancer cells via the ANO1 pathway","volume":"11","author":"Lu","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib154","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2295384","article-title":"Fusobacterium nucleatum promotes inflammatory and anti-apoptotic responses in colorectal cancer cells via ADP-heptose release and ALPK1\/TIFA axis activation","volume":"16","author":"Martin-Gallausiaux","year":"2024","journal-title":"Gut Microbes"},{"issue":"756","key":"10.1016\/j.canlet.2026.218305_bib155","doi-asserted-by":"crossref","first-page":"eabn4948","DOI":"10.1126\/scisignal.abn4948","article-title":"Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling","volume":"15","author":"Udayasuryan","year":"2022","journal-title":"Sci. Signal."},{"key":"10.1016\/j.canlet.2026.218305_bib156","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2024.04.226","article-title":"Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin\/\u03b2-catenin\/GPX4 axis in colorectal cancer","volume":"220","author":"Li","year":"2024","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.canlet.2026.218305_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107171","article-title":"Deciphering the role of Enterococcus faecium cytidine deaminase in gemcitabine resistance of gallbladder cancer","volume":"300","author":"Jiang","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.canlet.2026.218305_bib158","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1002\/ijc.32920","article-title":"Colibactin-positive Escherichia coli induce a procarcinogenic immune environment leading to immunotherapy resistance in colorectal cancer","volume":"146","author":"Lop\u00e8s","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib159","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2320291","article-title":"The colibactin-producing Escherichia coli alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance","volume":"16","author":"de Oliveira Alves","year":"2024","journal-title":"Gut Microbes"},{"issue":"3","key":"10.1016\/j.canlet.2026.218305_bib160","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/gutjnl-2020-323392","article-title":"Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies","volume":"71","author":"Oster","year":"2022","journal-title":"Gut"},{"issue":"13","key":"10.1016\/j.canlet.2026.218305_bib161","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1016\/j.cell.2024.05.029","article-title":"Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome","volume":"187","author":"Derosa","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib162","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10555-023-10138-7","article-title":"The emerging role of the gut microbiome in cancer cell plasticity and therapeutic resistance","volume":"43","author":"Mondal","year":"2024","journal-title":"Cancer Metastasis Rev"},{"issue":"11","key":"10.1016\/j.canlet.2026.218305_bib163","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.ccell.2023.09.012","article-title":"Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring","volume":"41","author":"Colbert","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib164","article-title":"Intestinal Akkermansia muciniphila complements the efficacy of PD1 therapy in MAFLD-related hepatocellular carcinoma","volume":"6","author":"Wu","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.canlet.2026.218305_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2022.127012","article-title":"Putative probiotics decrease cell viability and enhance chemotherapy effectiveness in human cancer cells: role of butyrate and secreted proteins","volume":"260","author":"Doublier","year":"2022","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.canlet.2026.218305_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112755","article-title":"Lactiplantibacillus plantarum inhibits colon cancer cell proliferation as function of its butyrogenic capability","volume":"149","author":"Botta","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib167","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2081010","article-title":"Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors","volume":"11","author":"Tomita","year":"2022","journal-title":"OncoImmunology"},{"issue":"24","key":"10.1016\/j.canlet.2026.218305_bib168","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.4161\/15384101.2014.964115","article-title":"Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy","volume":"13","author":"Yano","year":"2014","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib169","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12032-024-02578-0","article-title":"Salmonella-based therapeutic strategies: improving tumor microenvironment and bringing new hope for cancer immunotherapy","volume":"42","author":"He","year":"2024","journal-title":"Med. Oncol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218305_bib170","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.4014\/jmb.1605.05024","article-title":"Combination therapy of Lactobacillus plantarum supernatant and 5-Fluouracil increases chemosensitivity in colorectal cancer cells","volume":"26","author":"An","year":"2016","journal-title":"J. Microbiol. Biotechnol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218305_bib171","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11274-024-03929-9","article-title":"The anticancer effect of potential probiotic L. fermentum and L. plantarum in combination with 5-fluorouracil on colorectal cancer cells","volume":"40","author":"Salek","year":"2024","journal-title":"World J. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib172","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s40425-019-0561-9","article-title":"Could the menagerie of the gut microbiome really cure cancer? Hope or hype","volume":"7","author":"Abid","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2026.218305_bib173","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3892\/ijo.2020.5096","article-title":"Probiotic-derived ferrichrome inhibits the growth of refractory pancreatic cancer cells","volume":"57","author":"Kita","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2026.218305_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113163","article-title":"Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models","volume":"151","author":"Panebianco","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2026.218305_bib175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jconrel.2023.09.028","article-title":"Delivery of short chain fatty acid butyrate to overcome fusobacterium nucleatum-induced chemoresistance","volume":"363","author":"Chen","year":"2023","journal-title":"J. Contr. Rel."},{"issue":"21","key":"10.1016\/j.canlet.2026.218305_bib176","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101199","article-title":"Multistage cooperative nanodrug combined with PD-L1 for enhancing antitumor chemoimmunotherapy","volume":"10","author":"Wang","year":"2021","journal-title":"Adv. Healthcare Mater."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib177","article-title":"Multi-omics of the gut microbial ecosystem in patients with microsatellite-instability-high gastrointestinal cancer resistant to immunotherapy","volume":"5","author":"Cheng","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.canlet.2026.218305_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107278","article-title":"Akkermansia muciniphila-derived pentadecanoic acid enhances oxaliplatin sensitivity in gastric cancer by modulating glycolysis","volume":"206","author":"Xu","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.canlet.2026.218305_bib179","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/s41564-024-01695-w","article-title":"Peptostreptococcus anaerobius mediates anti-PD1 therapy resistance and exacerbates colorectal cancer via myeloid-derived suppressor cells in mice","volume":"9","author":"Liu","year":"2024","journal-title":"Nat. Microbiol."},{"issue":"46","key":"10.1016\/j.canlet.2026.218305_bib180","doi-asserted-by":"crossref","first-page":"31794","DOI":"10.1021\/acsnano.4c07000","article-title":"Targeted elimination of the oral pathogen to overcome chemoresistance of oral squamous cell carcinoma by biologically derived nanotherapeutics","volume":"18","author":"Pang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2026.218305_bib181","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1125809","article-title":"Impact of intravesical bacillus calmette-gu\u00e9rin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer","volume":"13","author":"James","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.canlet.2026.218305_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217077","article-title":"Pan-cancer atlas of tumor-resident microbiome, immunity and prognosis","volume":"598","author":"Sheng","year":"2024","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.canlet.2026.218305_bib183","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.trecan.2023.03.005","article-title":"The intratumoral microbiota: friend or foe?","volume":"9","author":"Ferrari","year":"2023","journal-title":"Trends Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2026.218305_bib184","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2421710122","article-title":"A signaling molecule from intratumor bacteria promotes trastuzumab resistance in breast cancer cells","volume":"122","author":"Qin","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.canlet.2026.218305_bib185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.trecan.2024.01.001","article-title":"Bacteria-derived L-lactate fuels cervical cancer chemoradiotherapy resistance","volume":"10","author":"Johnston","year":"2024","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib186","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1038\/s41467-024-51534-z","article-title":"Probiotics functionalized with a gallium-polyphenol network modulate the intratumor microbiota and promote anti-tumor immune responses in pancreatic cancer","volume":"15","author":"Han","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218305_bib187","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.actbio.2024.06.042","article-title":"Antibacterial tellurium-containing polycarbonate drug carriers to eliminate intratumor bacteria for synergetic chemotherapy against colorectal cancer","volume":"185","author":"Hu","year":"2024","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib188","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41392-023-01491-8","article-title":"Destroying pathogen-tumor symbionts synergizing with catalytic therapy of colorectal cancer by biomimetic protein-supported single-atom nanozyme","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib189","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1158\/1078-0432.CCR-20-2065","article-title":"Intratumoral injection of clostridium novyi-NT spores in patients with treatment-refractory advanced solid tumors","volume":"27","author":"Janku","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218305_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217459","article-title":"Modulating the gut microbiota: a novel perspective in colorectal cancer treatment","volume":"612","author":"Bai","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218305_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2021.102361","article-title":"The alterations of microbiota and pathological conditions in the gut of patients with colorectal cancer undergoing chemotherapy","volume":"68","author":"Yixia","year":"2021","journal-title":"Anaerobe"},{"issue":"2","key":"10.1016\/j.canlet.2026.218305_bib192","doi-asserted-by":"crossref","DOI":"10.3390\/nu15020356","article-title":"Postoperative probiotics administration attenuates gastrointestinal complications and gut microbiota dysbiosis caused by chemotherapy in colorectal cancer patients","volume":"15","author":"Huang","year":"2023","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.canlet.2026.218305_bib193","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1016\/j.clnu.2021.10.004","article-title":"Impact of synbiotics treatment on bacteremia induced during neoadjuvant chemotherapy for esophageal cancer: a randomised controlled trial","volume":"40","author":"Fukaya","year":"2021","journal-title":"Clin. Nutr."},{"issue":"6","key":"10.1016\/j.canlet.2026.218305_bib194","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30328","article-title":"The effects of LactoCare synbiotic administration on chemotherapy-induced nausea, vomiting, diarrhea, and constipation in children with ALL: a double-blind randomized clinical trial","volume":"70","author":"Eghbali","year":"2023","journal-title":"Pediatr. Blood Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2026.218305_bib195","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ijc.33557","article-title":"Clinical impact of probiotics on the efficacy of anti-PD-1 monotherapy in patients with nonsmall cell lung cancer: a multicenter retrospective survival analysis study with inverse probability of treatment weighting","volume":"149","author":"Takada","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218305_bib196","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.618150","article-title":"A phase II randomized clinical trial and mechanistic studies using improved probiotics to prevent oral mucositis induced by concurrent radiotherapy and chemotherapy in nasopharyngeal carcinoma","volume":"12","author":"Xia","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.canlet.2026.218305_bib197","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/cncr.31907","article-title":"A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma","volume":"125","author":"Jiang","year":"2019","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2026.218305_bib198","doi-asserted-by":"crossref","DOI":"10.3390\/ph16050654","article-title":"Probiotics in the treatment of radiotherapy-induced oral mucositis: systematic review with meta-analysis","volume":"16","author":"Minervini","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.canlet.2026.218305_bib199","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001723","article-title":"Gut microbiota associated with the mitigation effect of synbiotics on adverse events of neoadjuvant chemotherapy in patients with esophageal cancer: a retrospective exploratory study","volume":"72","author":"Sugimoto","year":"2023","journal-title":"J. Med. Microbiol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218305_bib200","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.clnu.2022.03.023","article-title":"Comparison of synbiotics combined with enteral nutrition and prophylactic antibiotics as supportive care in patients with esophageal cancer undergoing neoadjuvant chemotherapy: a multicenter randomized study","volume":"41","author":"Motoori","year":"2022","journal-title":"Clin. Nutr."},{"issue":"6","key":"10.1016\/j.canlet.2026.218305_bib201","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00262-024-03686-6","article-title":"Synergistic immunomodulatory effect of synbiotics pre- and postoperative resection of pancreatic ductal adenocarcinoma: a randomized controlled study","volume":"73","author":"Maher","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib202","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13054-018-2167-x","article-title":"Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial","volume":"22","author":"Shimizu","year":"2018","journal-title":"Crit. Care"},{"issue":"4","key":"10.1016\/j.canlet.2026.218305_bib203","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1158\/2159-8290.CD-21-0808","article-title":"A natural polyphenol exerts antitumor activity and circumvents Anti-PD-1 resistance through effects on the gut microbiota","volume":"12","author":"Messaoudene","year":"2022","journal-title":"Cancer Discov."},{"issue":"9","key":"10.1016\/j.canlet.2026.218305_bib204","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.7150\/thno.54476","article-title":"Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2026.218305_bib205","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156161","article-title":"Cepharanthine sensitizes gastric cancer cells to chemotherapy by targeting TRIB3-FOXO3-FOXM1 axis to inhibit autophagy","volume":"135","author":"Lu","year":"2024","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.canlet.2026.218305_bib206","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.1002\/ptr.7240","article-title":"Gut microbiota enhances the chemosensitivity of hepatocellular carcinoma to 5-fluorouracil in vivo by increasing curcumin bioavailability","volume":"35","author":"Jin","year":"2021","journal-title":"Phytother Res."},{"issue":"27","key":"10.1016\/j.canlet.2026.218305_bib207","article-title":"PUM1 promotes tumor progression by activating DEPTOR-meditated glycolysis in gastric cancer","volume":"10","author":"Yin","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"4-6","key":"10.1016\/j.canlet.2026.218305_bib208","first-page":"282","article-title":"Riboflavin supplementation promotes butyrate production in the absence of gross compositional changes in the gut microbiota","volume":"38","author":"Liu","year":"2023","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib209","doi-asserted-by":"crossref","DOI":"10.3390\/nu13010201","article-title":"Genistein reduces the risk of local mammary cancer recurrence and ameliorates alterations in the gut microbiota in the offspring of Obese dams","volume":"13","author":"Andrade","year":"2021","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.canlet.2026.218305_bib210","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1158\/2159-8290.CD-20-0537","article-title":"A procarcinogenic Colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates notch and \u03b2-Catenin axes","volume":"11","author":"Parida","year":"2021","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib211","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2038852","article-title":"Fusobacterium nucleatum promotes colorectal cancer cells adhesion to endothelial cells and facilitates extravasation and metastasis by inducing ALPK1\/NF-\u03baB\/ICAM1 axis","volume":"14","author":"Zhang","year":"2022","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib212","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.1980347","article-title":"Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322\/CCL20 axis and M2 polarization","volume":"13","author":"Xu","year":"2021","journal-title":"Gut Microbes"},{"issue":"3","key":"10.1016\/j.canlet.2026.218305_bib213","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00447-23","article-title":"Candida albicans promotes oral cancer via IL-17A\/IL-17RA-Macrophage axis","volume":"14","author":"Wang","year":"2023","journal-title":"mBio"},{"issue":"8","key":"10.1016\/j.canlet.2026.218305_bib214","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1158\/2159-8290.CD-21-1273","article-title":"Human Colon cancer-derived Clostridioides difficile strains drive colonic tumorigenesis in mice","volume":"12","author":"Drewes","year":"2022","journal-title":"Cancer Discov."},{"issue":"25","key":"10.1016\/j.canlet.2026.218305_bib215","doi-asserted-by":"crossref","first-page":"14013","DOI":"10.1002\/anie.202102059","article-title":"Dual gate-controlled therapeutics for overcoming bacterium-induced drug resistance and potentiating cancer immunotherapy","volume":"60","author":"Zhang","year":"2021","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"16","key":"10.1016\/j.canlet.2026.218305_bib216","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.scib.2024.06.016","article-title":"An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria","volume":"69","author":"Chen","year":"2024","journal-title":"Sci Bull (Beijing)"},{"issue":"4","key":"10.1016\/j.canlet.2026.218305_bib217","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00062-22","article-title":"Reassessment of historical clinical trials supports the effectiveness of phage therapy","volume":"35","author":"Marongiu","year":"2022","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib218","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2390720","article-title":"Role of bacteriophages in shaping gut microbial community","volume":"16","author":"Mahmud","year":"2024","journal-title":"Gut Microbes"},{"issue":"6","key":"10.1016\/j.canlet.2026.218305_bib219","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.chom.2025.05.004","article-title":"Bacteroides fragilis promotes chemoresistance in colorectal cancer, and its elimination by phage VA7 restores chemosensitivity","volume":"33","author":"Ding","year":"2025","journal-title":"Cell Host Microbe"},{"issue":"5","key":"10.1016\/j.canlet.2026.218305_bib220","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuab017","article-title":"Bacteriophage manipulation of the microbiome associated with tumour microenvironments-can this improve cancer therapeutic response?","volume":"45","author":"Kabwe","year":"2021","journal-title":"FEMS Microbiol. Rev."},{"issue":"9","key":"10.1016\/j.canlet.2026.218305_bib221","volume":"13","author":"Cui","year":"2024","journal-title":"Compreh. Rev. Phage Ther. Phage-Based Drug Develop. Antib. (Basel)"},{"issue":"11","key":"10.1016\/j.canlet.2026.218305_bib222","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.chom.2024.09.004","article-title":"Rapid design of bacteriophage cocktails to suppress the burden and virulence of gut-resident carbapenem-resistant Klebsiella pneumoniae","volume":"32","author":"Rotman","year":"2024","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.canlet.2026.218305_bib223","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.chom.2019.01.008","article-title":"Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis","volume":"25","author":"Gogokhia","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"9","key":"10.1016\/j.canlet.2026.218305_bib224","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41551-019-0423-2","article-title":"Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy","volume":"3","author":"Zheng","year":"2019","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib225","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12916-022-02287-3","article-title":"Targeted therapies for cancer","volume":"20","author":"Zhou","year":"2022","journal-title":"BMC Med."},{"issue":"12","key":"10.1016\/j.canlet.2026.218305_bib226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0297-0","article-title":"Bacteria-cancer interactions: bacteria-based cancer therapy","volume":"51","author":"Duong","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.canlet.2026.218305_bib227","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115579","article-title":"Designing live bacterial therapeutics for cancer","volume":"221","author":"Lee","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2026.218305_bib228","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.biochi.2020.07.020","article-title":"Bacteria and bacterial anticancer agents as a promising alternative for cancer therapeutics","volume":"177","author":"Baindara","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.canlet.2026.218305_bib229","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123342","article-title":"Living therapeutics: precision diagnosis and therapy with engineered bacteria","volume":"321","author":"Xie","year":"2025","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib230","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00253-024-13378-x","article-title":"Precision tumor treatment utilizing bacteria: principles and future perspectives","volume":"109","author":"Liu","year":"2025","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib231","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41392-024-01973-3","article-title":"Aptamer-drug conjugates-loaded bacteria for pancreatic cancer synergistic therapy","volume":"9","author":"Xiao","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218305_bib232","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117754","article-title":"Bacteriotherapy in gastrointestinal cancer","volume":"254","author":"Soleimanpour","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.canlet.2026.218305_bib233","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123810","article-title":"Oral probiotics microgel plus galunisertib reduced TGF-\u03b2 blockade resistance and enhanced anti-tumor immune responses in colorectal cancer","volume":"652","author":"Niu","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.canlet.2026.218305_bib234","doi-asserted-by":"crossref","DOI":"10.1016\/j.seminoncol.2025.152376","article-title":"Are we there yet? Gut microbiota for cancer diagnosis, prognosis and treatment","volume":"52","author":"Ord\u00f3\u00f1ez","year":"2025","journal-title":"Semin. Oncol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218305_bib235","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","article-title":"Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial","volume":"29","author":"Routy","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218305_bib236","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104403","article-title":"A viable remedy for overcoming resistance to anti-PD-1 immunotherapy: fecal microbiota transplantation","volume":"200","author":"Meng","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"12","key":"10.1016\/j.canlet.2026.218305_bib237","doi-asserted-by":"crossref","DOI":"10.3390\/cells11121900","article-title":"Complex role of microbiome in pancreatic tumorigenesis: potential therapeutic implications","volume":"11","author":"Amara","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib238","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1038\/s41467-020-18127-y","article-title":"Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma","volume":"11","author":"Ianiro","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218305_bib239","article-title":"Synergistic ROS\/enzyme dual-responsive oral drug delivery system: a novel multi-mechanistic platform for spatiotemporal control and overcoming drug resistance in colorectal cancer therapy","volume":"33","author":"Sun","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.canlet.2026.218305_bib240","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.biomaterials.2016.10.037","article-title":"Bacterial protoplast-derived nanovesicles for tumor targeted delivery of chemotherapeutics","volume":"113","author":"Kim","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2026.218305_bib241","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1545334","article-title":"Resynthesis of synthetic biology techniques: combining engineered bacteria with other antitumour therapies","volume":"16","author":"Chang","year":"2025","journal-title":"Front. Microbiol."},{"issue":"11-12","key":"10.1016\/j.canlet.2026.218305_bib242","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s10495-024-01986-x","article-title":"Targeted delivery of FAK siRNA by engineered exosomes to reverse cetuximab resistance via activating paraptosis in colon cancer","volume":"29","author":"Geng","year":"2024","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib243","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12951-020-0576-x","article-title":"Core-shell nanoparticles suppress metastasis and modify the tumour-supportive activity of cancer-associated fibroblasts","volume":"18","author":"Kov\u00e1cs","year":"2020","journal-title":"J. Nanobiotechnol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218305_bib244","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.chom.2024.05.015","article-title":"Antibiotic resistance: a key microbial survival mechanism that threatens public health","volume":"32","author":"Abbas","year":"2024","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.canlet.2026.218305_bib245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043110","article-title":"Bacterial infections and cancer: exploring this association and its implications for cancer patients","volume":"24","author":"Yusuf","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib246","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2468-1253(23)00281-9","article-title":"Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis","volume":"9","author":"Hong","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"20","key":"10.1016\/j.canlet.2026.218305_bib247","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015108","article-title":"IRAK3 knockout and wildtype THP-1 monocytes as models for endotoxin detection assays and Fusobacterium nucleatum bacteriophage FNU1 cytokine induction","volume":"24","author":"Binte Mohamed Yakob Adil","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.canlet.2026.218305_bib248","doi-asserted-by":"crossref","DOI":"10.1080\/20002297.2024.2344272","article-title":"A review and new perspective on oral bacteriophages: manifestations in the ecology of oral diseases","volume":"16","author":"Guo","year":"2024","journal-title":"J. Oral Microbiol."},{"issue":"2","key":"10.1016\/j.canlet.2026.218305_bib249","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1021\/acs.chemrev.4c00681","article-title":"Engineering phages to fight multidrug-resistant bacteria","volume":"125","author":"Peng","year":"2025","journal-title":"Chem. Rev."},{"key":"10.1016\/j.canlet.2026.218305_bib250","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1055427","article-title":"Bacteriophage-mediated manipulations of microbiota in gastrointestinal diseases","volume":"13","author":"El Haddad","year":"2022","journal-title":"Front. Microbiol."},{"issue":"12","key":"10.1016\/j.canlet.2026.218305_bib251","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1136\/gutjnl-2025-335077","article-title":"Translational strategies for oral delivery of faecal microbiota transplantation","volume":"74","author":"Kamath","year":"2025","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.canlet.2026.218305_bib252","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bcp.2008.04.019","article-title":"The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection: implications for cancer therapy","volume":"76","author":"Bronckaers","year":"2008","journal-title":"Biochem. Pharmacol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526000686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526000686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T03:09:54Z","timestamp":1772075394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526000686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":252,"alternative-id":["S0304383526000686"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218305","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of the microbiota in cancer drug resistance and emerging therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218305"}}